MyFinsight
Home
Blog
About
Contact
Proceeds from issuance of
common stock and...
$3,225,000
Net cash provided by
financing activities
$3,209,250
Canceled cashflow
$15,750
Net change in cash
and cash...
$755,941
Canceled cashflow
$2,453,309
Payment of other
issuance costs for...
$15,750
Depreciation and
amortization
$633,340
Accounts payable and
accrued expenses
$335,951
Stock-based compensation
$35,018
Amortization of debt discount
and finance fees
$12,122
Net change in cash
and cash...
$755,941
Net cash used in
operating activities
-$2,417,309
Net cash used in
investing activity
-$36,000
Canceled cashflow
$1,016,431
Net loss
-$2,152,471
something is missing
-$880,497
Payments made for
capitalized software
$36,000
Prepaid expenses and
other current assets
$323,604
Change in fair value of
derivative liabilities
$76,264
Change in operating
lease asset and...
-$904
Back
Back
Cash Flow
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
source: myfinsight.com